Highlight notices are calls for projects to answer a specific research question that has been identified by our Diabetes Research Steering Groups.
They are different from our strategic calls as instead of being funded from a specific fund, the applications to highlight notices are included in our project grants round which run twice per year. Money for our highlight notices is not ringfenced and the applications are in competition with all other applications in the project grant round.
On this page you can find our open research highlight notices and an archive of previous highlight notices.
Open research highlight notice
Restoring the glucagon safety net: Improving the experience of hypoglycaemia in type 1 diabetes
Hypoglycaemia is a major clinical and day-to-day challenge in type 1 diabetes and has been identified as a research priority by people living with diabetes through the James Lind Alliance Type 1 Diabetes Priority Setting Partnership. Despite advances in insulin delivery and glucose monitoring, hypoglycaemia remains common, carrying immediate clinical risks and lasting effects on cognition, confidence, self-management and quality of life. Improving outcomes requires not only reducing hypoglycaemia but improving how it is experienced and managed in everyday life.
This Highlight Notice aims to support research that addresses both the immediate and underlying causes of hypoglycaemia by utilising and improving our understanding of glucagon to reduce risk, improve recovery, and restore confidence and safety for people living with type 1 diabetes.
Read the highlight notice (PDF, 1.18MB).
Highlight notice archive
2026
- Addressing pre-pregnancy gestational diabetes. Read the highlight notice (PDF, 119KB) and plain English summary (PDF, 77KB).
- Applying diabetes technology during the hospital pathway to improve care for people living with diabetes. Read the highlight notice (PDF, 881KB) and plain English summary (PDF, 563KB).
2025
- Improving the understanding of diabetes in underserved communities to improve targeted interventions and reduce health inequalities. Read the highlight notice and plain English summary.
- Leveraging the insights of children and young people with type 1 diabetes to shape research. Read the highlight notice and plain English summary.
2024
- Addressing health inequalities in diabetes. Read the highlight notice and plain English summary.
- Implementing glucose monitoring technologies in hospitals and care homes for people living with diabetes. Read the highlight notice and plain English summary.
- Improving access to, and understanding of, support for people with type 2 diabetes who want to put their condition into, or maintain remission. Read the highlight notice and plain English summary.
2023
- Improving understanding, prevention, treatment, and care of people living with early-onset type 2 diabetes. Read the highlight notice and plain English summary.
- Identifying and addressing problematic polypharmacy in people with diabetes. In partnership with Polypharmacy UK. Read the highlight notice and plain English summary.
- Reducing sight loss in people living with diabetes. In partnership with Moorfields Eye Charity, Fight for Sight, and The Macular Society. Read the highlight notice and plain English summary.
2022
- Understanding the link between COVID-19 and diabetes. Read the highlight notice.
- Understanding the clinical relevance of c-peptide concentrations in type 1 diabetes. Read the highlight notice and plain English summary.
2021
- Understand the pathogenesis of diabetes that develops atypically, or in minority populations. In partnership with Cystic Fibrosis Trust. Read the highlight notice and plain English summary.
- Diabetes and foot care. In partnership with Great Foundations. Read the highlight notice and plain English summary.
2020
- New glucose monitoring technologies in inpatient care. Read the highlight notice.
- Practice-based pharmacy research into diabetes. In partnership with Pharmacy Research UK. Read the highlight notice.
2019
- Menopause and diabetes self-management. Read the highlight notice.
